Wintermute Ventures reviewed approximately 600 companies last year and funded only 4% of them. The venture arm of algorithmic ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

The FDA has approved Flow, a prescription home-use cranial electrotherapy stimulation device, for treating moderate to severe major depressive disorder (MDD) in adults aged 18 years and older. It can ...

The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can cause side ...

Big news: The FDA has given the green light to Flow's FL-100, the first device you can use at home to treat moderate to severe depression (for adults 18+ who aren't resistant to meds). With US ...

Flow Neuroscience's FL-100 headset, using transcranial direct current stimulation for at-home depression treatment, has FDA approval for major depressive disorder. Available in the US by late 2026 ...

Bengaluru: The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can ...